No abstract available.
Carcinoma, Renal Cell* ; Survival Rate*

No abstract available.
Laser Coagulation* ; Prostatic Hyperplasia*

No abstract available.
Carcinoma, Renal Cell*

No abstract available.
Carcinoma, Renal Cell*

No abstract available.

There is no single characteristic clinical or radiological feature to diagnose xanthogranulomatous pyelonephritis, so it makes accurate preoperative diagnosis difficult. In our case, the renal parenchyme of affected kidney was well preserved on excretory urogram. The abnormal finding was only a filling defect within the right upper pelvocalyceal system. Herein we report a case of xanthogranulomatous pyelonephritis in a 18 years old girl which was confused with renal pelvic tumor.
Adolescent ; Diagnosis ; Female ; Humans ; Kidney ; Pyelonephritis, Xanthogranulomatous*

Most renal cell carcinomas are solid but contain small cystic areas. Sometimes the cystic component predominates and such lesions are called cystic renal cell carcinomas. The radiographic and pathologic findings of cystic renal cell carcinoma are often more confusing and less specific than the findings of solid renal cell carcinoma. Multilocular cystic renal cell carcinoma is one form of cystic renal cell carcinoma variants and results from intrinsic multiloculated growth. A presumptive diagnosis of multilocular cystic renal cell carcinoma was made preoperatively in a 38-year-old woman and it was treated with radical nephrectomy, so we report this case with brief review of the literatures.
Adult ; Carcinoma, Renal Cell* ; Diagnosis ; Female ; Humans ; Nephrectomy

Since continent urinary diversion and bladder substitution after cystoprostatectomy have been offered as alternative to standard urinary diversion, increasing numbers of patients seek to avoid a wet stoma. So since 1988 we have used a pouch constructed from a combination of large and small bowel(Mainz pouch), which offers a low pressure reservoir of adequate capacity, antirefluxing ureteral reimplantation and continent reservoir. Initial applications of the Mainz pouch were for bladder augmentation after subtotal cystectomy and for continent urinary diversion. Current indications have been extended to complete bladder substitution after radical cystectomy with anastomosis of the pouch to the membranous urethra. A total or 15 patients underwent a Mainz pouch procedure ;6 for bladder augmentation, 8 for continent urinary diversion and 1 for total bladder substitution after radical cystectomy. All bladder augmentation cases, 4 of 8 diversion cases and substitution case are completely dry day and night. There are no significant perioperative morbidity and mortality.
Cystectomy ; Humans ; Mortality ; Replantation ; Ureter ; Urethra ; Urinary Bladder ; Urinary Diversion

Recently, to find a change of cellular immunologic function, the development of monoclonal anti-body for surface antigen of T cell subsets is used as an important method of quantitative and functional measure in T cell subsets. We evaluated the T cell subsets in the peripheral blood of 145 normal control group and 106 bladder cancer group which was diagnosed by tissue pathology during the period from June 1986 to June 1992. The results of this study showed that CD3 of T cell subsets was significantly decreased in bladder cancer group as compared with normal control group(p<0.05) and significantly decreased in T1 and T1 groups of bladder cancer groups(p<0.05). But CD4/CD8 ratio was not decreased in bladder cancer group as compared with normal control group.
Antigens, Surface ; Humans ; Immunity, Cellular ; Pathology ; T-Lymphocyte Subsets* ; Urinary Bladder Neoplasms* ; Urinary Bladder*

We measured serum CA19-9 from March 1990 to June 1992 in 63 cases of normal controls, 56 cases or bladder cancer, 32 cases of renal cell carcinoma, 8 cases of prostatic carcinoma, 4 cases of penile cancer. 2 cases of testicular cancer and 3 cases of carcinoma of gastrointestinal tract with metastasis to the retroperitoneum. The results of this study were that serum levels of CA19-9 in urinary bladder cancer, renal cell carcinoma and prostatic carcinoma were statistically significant. However, sensitivity was low, 14. 29% for urinary bladder cancer, 18.75% for renal cell carcinoma. 12.5 % for prostatic carcinoma and specificity was 95.2%. In renal cell carcinoma, there was no change in serum level between stages. However there was a statistically significant difference (p<0.05) between low stage(A, B) and high stage(C, D) urinary cancers. We suggest that serum CA19-9 levels cannot be used as a screening test or prognosis indicator in tumors of the genitourinary tract ; however it can be helpful in differentiating between low and high stage urinary bladder cancers.
Carcinoma, Renal Cell ; Gastrointestinal Tract ; Male ; Mass Screening ; Neoplasm Metastasis ; Penile Neoplasms ; Prognosis ; Sensitivity and Specificity ; Testicular Neoplasms ; Urinary Bladder ; Urinary Bladder Neoplasms ; Urogenital Neoplasms*